#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13796	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2466	689.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1939	1939	T	933	T,G,C	928,4,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13796	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2466	689.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1673	1673	C	872	C,A	871,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23204	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3984	725.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1879	1879	A	993	A	993	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23204	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3984	725.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2513	2513	C	797	C,T	794,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23204	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3984	725.8	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3139	3139	T	779	T,G,C	777,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23204	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3984	725.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2587	2587	A	760	A,G,C,T	754,2,2,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1558	folP	852	852	93.78	folP.l15.c4.ctg.1	1998	97.3	0	.	p	.	0	G5V	NONSYN	13	15	GGT	585	587	GTT	107;107;108	G;T;T	107;107;108	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1558	folP	852	852	93.78	folP.l15.c4.ctg.1	1998	97.3	0	.	p	.	0	E12K	NONSYN	34	36	GAA	606	608	AAA	126;127;129	A;A;A	126;127;129	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1558	folP	852	852	93.78	folP.l15.c4.ctg.1	1998	97.3	0	.	p	.	0	F31L	NONSYN	91	93	TTT	663	665	TTG	166;167;169	T,G;T;G	165,1;167;169	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1558	folP	852	852	93.78	folP.l15.c4.ctg.1	1998	97.3	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	696	698	CAA	191;188;190	C;A;A	191;188;190	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1558	folP	852	852	93.78	folP.l15.c4.ctg.1	1998	97.3	0	.	p	.	0	S75P	NONSYN	223	225	TCC	795	797	CCT	175;173;171	C;C,A;T,A	175;172,1;170,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1558	folP	852	852	93.78	folP.l15.c4.ctg.1	1998	97.3	0	.	p	.	0	V87A	NONSYN	259	261	GTA	831	833	GCA	157;155;154	G;C;A	157;155;154	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1558	folP	852	852	93.78	folP.l15.c4.ctg.1	1998	97.3	0	.	p	.	0	V130L	NONSYN	388	390	GTC	960	962	CTC	182;183;182	C;T;C	182;183;182	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1558	folP	852	852	93.78	folP.l15.c4.ctg.1	1998	97.3	0	.	p	.	0	R135C	NONSYN	403	405	CGC	975	977	TGT	189;189;189	T;G,T;T	189;188,1;189	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1558	folP	852	852	93.78	folP.l15.c4.ctg.1	1998	97.3	0	.	p	.	0	T137A	NONSYN	409	411	ACG	981	983	GCG	196;195;195	G;C;G,T	196;195;194,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1558	folP	852	852	93.78	folP.l15.c4.ctg.1	1998	97.3	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1023	1025	AAG	200;197;199	A;A;G,T	200;197;198,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1558	folP	852	852	93.78	folP.l15.c4.ctg.1	1998	97.3	0	.	p	.	0	T152N	NONSYN	454	456	ACC	1026	1028	AAT	201;202;204	A,G;A,C;T	200,1;201,1;204	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1558	folP	852	852	93.78	folP.l15.c4.ctg.1	1998	97.3	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1224	1226	TTG	126;125;124	T;T,G;G	125;122,2;123	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1558	folP	852	852	93.78	folP.l15.c4.ctg.1	1998	97.3	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1254	1256	AGC	129;132;133	A;G;C	129;132;133	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1558	folP	852	852	93.78	folP.l15.c4.ctg.1	1998	97.3	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1323	1325	CTG	117;115;115	C;T;G,C	117;115;114,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1558	folP	852	852	93.78	folP.l15.c4.ctg.1	1998	97.3	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1329	1331	TCC	110;111;110	T;C;C	110;111;110	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1558	folP	852	852	93.78	folP.l15.c4.ctg.1	1998	97.3	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1344	1346	GTG	122;121;121	G,T;T,C;G	121,1;120,1;121	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1558	folP	852	852	93.78	folP.l15.c4.ctg.1	1998	97.3	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1395	1397	GCG	142;143;143	G,T;C;G	141,1;143;143	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4996	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3794	164.2	1	SNP	p	S91F	0	.	.	271	273	TCC	837	839	TCC	188;190;191	T;C;C	188;190;191	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4996	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3794	164.2	1	SNP	p	D95G	0	.	.	283	285	GAC	849	851	GAC	202;203;201	G;A;C,A	202;203;200,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4996	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3794	164.2	1	SNP	p	D95N	0	.	.	283	285	GAC	849	851	GAC	202;203;201	G;A;C,A	202;203;200,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	531	1764	mtrR	633	633	99.68	mtrR.l15.c17.ctg.1	1935	113.7	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	1109	1109	T	192	T,A	191,1	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1096	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1400	97.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4476	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3497	159.8	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1770	1772	ATC	224;225;225	A,C;T;C	223,1;225;225	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4476	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3497	159.8	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1923	1925	GCA	199;202;204	G;C;A	199;202;204	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4476	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3497	159.8	1	SNP	p	D86N	0	.	.	256	258	GAC	876	878	GAC	198;197;195	G;A,G,C;C,A	198;195,1,1;194,1	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4476	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3497	159.8	1	SNP	p	S87I	0	.	.	259	261	AGT	879	881	AGT	196;197;197	A;G;T	196;197;197	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4476	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3497	159.8	1	SNP	p	S87R	0	.	.	259	261	AGT	879	881	AGT	196;197;197	A;G;T	196;197;197	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4476	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3497	159.8	1	SNP	p	S87W	0	.	.	259	261	AGT	879	881	AGT	196;197;197	A;G;T	196;197;197	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4476	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3497	159.8	1	SNP	p	S88P	0	.	.	262	264	TCC	882	884	TCC	195;195;199	T;C;C,A	195;195;198,1	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4144	parE	1986	1986	99.95	parE.l6.c4.ctg.1	3065	168.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1752	1754	GGC	214;215;215	G;G,A;C	214;214,1;215	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	3856	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	162.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1550	1552	GCA	215;214;216	G,T;C;A,T	214,1;214;215,1	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3856	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	162.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1553	1555	ATC	216;212;212	A;T;C	216;212;212	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3856	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	162.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1565	1567	GTG	212;215;214	G,T;T;G	210,2;215;214	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3856	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	162.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1565	1567	GTG	212;215;214	G,T;T;G	210,2;215;214	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3856	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	162.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2069	2071	ACC	195;197;196	A;C;C	195;197;196	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3856	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	162.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2123	2125	GCG	215;211;211	G,T;C;G	213,1;211;211	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3856	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	162.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2123	2125	GCG	215;211;211	G,T;C;G	213,1;211;211	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3856	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	162.9	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2246	2248	GGT	261;259;259	G;G,T;T	261;258,1;259	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3856	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	162.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2255	2257	GGC	259;256;257	G;G,T;C,T	259;255,1;256,1	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3856	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	162.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2273	2275	CCG	259;261;266	C,A,G;C,A;G,A,T	255,1,2;259,1;263,1,2	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5252	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3569	183.6	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1884	1886	CTG	224;224;228	C;T,C;G,A	224;223,1;227,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2222	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2307	120.1	0	.	p	.	0	S22G	NONSYN	64	66	AGC	702	704	GGC	170;172;173	G,A;G;C	169,1;172;173	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2222	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2307	120.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	884	884	C	172	C,A	171,1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	305	30.8	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	23;25;30	T;T;A	23;25;30	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	305	30.8	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	62;62;62	C;A;T	62;62;62	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	305	30.8	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	62;62;62	A;G;T	62;62;62	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	305	30.8	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	62;62;62	T;A;C	62;62;62	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	305	30.8	0	.	p	.	0	R307E	NONSYN	919	921	AGA	161	163	GAA	2;2;2	G;A;A	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	305	30.8	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	305	30.8	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	3;3;3	A;T;C	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	305	30.8	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	3;3;3	T;C;G	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	305	30.8	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	305	30.8	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	3;3;3	A;G;C	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	305	30.8	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	298	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	305	30.8	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	3;3;3	G;T;T	3;3;3	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2944	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	2160	169.9	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1214	1214	T	236	T,G	235,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2944	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	2160	169.9	1	SNP	p	G120K	0	.	.	358	360	GGT	941	943	GGT	263;261;264	G;G;T,G	263;261;263,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2944	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	2160	169.9	1	SNP	p	A121D	0	.	.	361	363	GCC	944	946	GCC	260;259;264	G;C,A;C,T	260;258,1;263,1	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2944	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	2160	169.9	1	SNP	p	A121N	0	.	.	361	363	GCC	944	946	GCC	260;259;264	G;C,A;C,T	260;258,1;263,1	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9326	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	5326	218.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1400	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1425	122.0	1	SNP	p	V57M	1	.	.	169	171	ATG	669	671	ATG	251;252;251	A;T;G	251;252;251	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
